BridgeBio Oncology Therapeutics, Inc. SEC filings BBOT
BridgeBio Oncology Therapeutics, Inc. has 185 filings in SEC EDGAR's recent list, going back to Dec 20, 2023. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Sep 1, 2026 | — |
| POS AM | Filing | Sep 1, 2026 | — |
| 424B3 | Prospectus | Aug 12, 2026 | — |
| 424B3 | Prospectus | Jun 22, 2026 | — |
| 424B3 | Prospectus | May 13, 2026 | — |
| 424B3 | Prospectus | May 6, 2026 | — |
| POS AM | Filing | Apr 30, 2026 | — |
| 424B3 | Prospectus | Apr 29, 2026 | — |
| 424B3 | Prospectus | Apr 23, 2026 | — |
| 424B3 | Prospectus | Mar 26, 2026 | — |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 424B3 | Prospectus | Jan 7, 2026 | — |
| 424B3 | Prospectus | Jan 7, 2026 | — |
| S-8 | Employee stock plan registration | Jan 2, 2026 | — |
| S-8 | Employee stock plan registration | Oct 10, 2025 | — |
| 424B3 | Prospectus | Sep 10, 2025 | — |
| S-1 | Registration statement | Aug 29, 2025 | — |
| POS AM | Post-effective amendment no. 1 to form s-4 | Aug 15, 2025 | — |
| 424B3 | Prospectus | Jul 22, 2025 | — |
| 424B4 | Prospectus | Jul 10, 2025 | — |
| S-4/A | Registration statement | Jul 9, 2025 | — |
| S-4/A | Registration statement | Jul 1, 2025 | — |
| S-4 | Registration for a merger or exchange | Jun 20, 2025 | — |
| 424B4 | Prospectus | Feb 13, 2024 | — |
| S-1MEF | Registration statement | Feb 8, 2024 | — |
| S-1/A | Amended registration statement | Feb 7, 2024 | — |
| S-1/A | Amended registration statement | Feb 2, 2024 | — |
| S-1 | Registration statement | Jan 18, 2024 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BBOT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1869105
- Former names
- Helix Acquisition Corp. II (until Aug 6, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.